Macleods Pharma and 2 others get SEBI go ahead for IPOs

Going by the draft papers, Macleods Pharmaceuticals' initial share sale is entirely an Offer For Sale (OFS) of up to 6.05 crore shares by promoters.
New Delhi: Three companies -- Macleods Pharmaceuticals, travel services provider TBO Tek and Suraj Estate Developers -- have received capital markets regulator Sebi's go ahead to raise funds through initial public offerings (IPOs). These firms, which filed their preliminary IPO papers with Sebi between December 2021 and March 2022, obtained Sebi's observations during May 17-20, an update...
New Delhi: Three companies -- Macleods Pharmaceuticals, travel services provider TBO Tek and Suraj Estate Developers -- have received capital markets regulator Sebi's go ahead to raise funds through initial public offerings (IPOs). These firms, which filed their preliminary IPO papers with Sebi between December 2021 and March 2022, obtained Sebi's observations during May 17-20, an update with Sebi showed on Monday.
Read also: Macleod Pharma gets CDSCO panel conditional nod to study FDC Sitagliptin, Metformin, Glimepiride